N-of-One Trials: Is This the Future of Oncology Drug Development?

Wednesday, March 9, 2016
1:15 – 2:30pm

N-of-One Trials: Is This the Future of Oncology Drug Development?

Moderator:

  • Brian Leyland-Jones, MD, PhD, Vice President of the Avera Center for Precision Oncology and the Department of Molecular and Experimental Medicine, Avera Cancer Institute, Consulting Professor, Stanford University School of Medicine

Panelists:

  • Michael Doherty, Head, Strategic Innovation, Roche and Genentech, Executive Adviser, Foundation Medicine Inc.
  • Sean Khozin, MD, MPH, Senior Medical Officer, Thoracic Oncologist, FDA
  • Nicholas J. Schork, PhD, Professor and Director, Human Biology, J. Craig Venter Institute
  • John J. Sninsky, PhD, Chief Scientific Officer, CareDX

Register-Button-green